AstraZeneca to invest over US$1bil in Massachusetts, boost workforce
NEW YORK: AstraZeneca said on Monday it would spend more than US$1 billion in Massachusetts as part of its broader US$50 billion US investment plan, a move expected to expand its workforce in the state by more than 50 per cent in the coming years.
AstraZeneca has announced plans to invest over US$1 billion in Massachusetts as part of its larger US$50 billion investment strategy, which is expected to expand its workforce in the state by more than 50 percent in the coming years. The company opened a new 570,000-square-foot, 18-story research and development center in Kendall Square, Cambridge, Massachusetts, focusing on developing treatments for cancer, chronic and rare diseases, as well as cell therapies.
The facility, which will house nearly 2,000 researchers and scientists, includes 10 floors of laboratories equipped with robotics, automation, and artificial intelligence.
Brief written by urgent.news from New Straits Times's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
